| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/27/2002 | US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt |
| 08/27/2002 | US6441186 Epothilone analogs |
| 08/27/2002 | US6441168 Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 08/27/2002 | US6441163 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 08/27/2002 | US6441153 Human carboxypeptidases and polynucleotides encoding the same |
| 08/27/2002 | US6441138 Protein which induces interferon-γ production by immunocompetent cell |
| 08/27/2002 | US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization |
| 08/27/2002 | US6441029 D-.gamma.-tocotrienol, 2-desmethyltocotrienol, d-.delta.-tocotrienol or d-tocotrienol and lovastatin |
| 08/27/2002 | US6441026 And an alkylating agent, an antimetabolite, a spindle poison, an epidophyllotoxin, an antibiotic, an enzyme, a topoisomerase inhibitor, a platinum coordination complex, a biological response modifier or a growth factor inhibitor |
| 08/27/2002 | US6441021 Type-iv collagenase inhibitors |
| 08/27/2002 | US6441019 Cyclocarbamate and cyclic amide derivatives |
| 08/27/2002 | US6441017 Inhibitors of prenyl-protein transferase |
| 08/27/2002 | US6441015 Tetrazole compounds as thyroid receptor ligands |
| 08/27/2002 | US6441010 Bi-aromatic compounds linked via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them |
| 08/27/2002 | US6440998 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative |
| 08/27/2002 | US6440992 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 08/27/2002 | US6440991 Ethers of 7-desmethlrapamycin |
| 08/27/2002 | US6440990 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 08/27/2002 | US6440989 Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
| 08/27/2002 | US6440974 Antitumor agents |
| 08/27/2002 | US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 08/27/2002 | US6440971 Binuclear complex |
| 08/27/2002 | US6440966 Benzenesulfonamide derivatives and their use as MEK inhibitors |
| 08/27/2002 | US6440962 Cardiovascular disorders, antiischemic agents |
| 08/27/2002 | US6440959 Inhibitors of cyclin-dependent kinases |
| 08/27/2002 | US6440955 Anti-inflammatory agents |
| 08/27/2002 | US6440953 Use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. |
| 08/27/2002 | US6440935 Such as cecropins and sarcotoxins |
| 08/27/2002 | US6440743 Supplying immobilizated polynucleotides |
| 08/27/2002 | US6440742 Recombinant AAV vector-based transduction system and use of same |
| 08/27/2002 | US6440736 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 08/27/2002 | US6440735 Dendritic cell vaccine containing telomerase reverse transcriptase for the treament of cancer |
| 08/27/2002 | US6440732 Checkpoint/repair genes involved with dna repair prior to replication; aging resistance; cancer therapy |
| 08/27/2002 | US6440730 Retroviral hybrid vectors pseudotyped with LCMV |
| 08/27/2002 | US6440451 Use of crataegus formulations for prophylaxis and treatment of neoplastic diseases |
| 08/27/2002 | US6440426 Antigen-containing formulation and methods of use thereof |
| 08/27/2002 | US6440419 J chain or portion thereof linked to at least one enzyme inhibitor; specifically binds to basolateral factor; eradi-cation of metastatic or nonpolarized cells; lung, breast, colon, ovarian and prostate carcinoma and endometriosis |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | US6440416 Primate antiidiotype antibody or fragment acting as immuno-genic functional mimic; preventive or therapeutic immune response against tumors, viruses, bacteria, rickettsia, mycoplasma, protozoa, fungi and multicellular parasites |
| 08/27/2002 | CA2069929C Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 08/27/2002 | CA2032311C 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors |
| 08/26/2002 | CA2373363A1 Antitumor and antiviral medications and method for producing the same |
| 08/22/2002 | WO2002064795A2 Putative human enzymes |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064791A2 Proteins and nucleic acids encoding same |
| 08/22/2002 | WO2002064790A2 Jfy1 protein induces rapid apoptosis |
| 08/22/2002 | WO2002064788A2 Compositions and methods relating to lung specific genes and proteins |
| 08/22/2002 | WO2002064776A2 Signal transduction proteins 15b3, 15b3-1 and 15b3-2, and related dna sequences |
| 08/22/2002 | WO2002064769A1 Novel disease marker |
| 08/22/2002 | WO2002064757A2 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064731A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 08/22/2002 | WO2002064626A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 08/22/2002 | WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | WO2002064612A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | WO2002064609A1 Crystal of pyrimidine nucleoside derivative |
| 08/22/2002 | WO2002064599A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064598A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064595A1 Triazolo compounds as mmp inhibitors |
| 08/22/2002 | WO2002064591A2 Carboline derivatives |
| 08/22/2002 | WO2002064590A2 Carboline derivatives |
| 08/22/2002 | WO2002064589A1 Laulimalide derivatives |
| 08/22/2002 | WO2002064587A1 Ratjadone derivatives for inhibiting cell growth |
| 08/22/2002 | WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof |
| 08/22/2002 | WO2002064578A1 Benzo thiadiazine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064575A1 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolins and the utilization thereof as anticoagulant and antithrombotic agents |
| 08/22/2002 | WO2002064572A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | WO2002064571A1 Pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064568A1 Pyridine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064564A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor |
| 08/22/2002 | WO2002064563A1 Novel benzoylguanidine salt |
| 08/22/2002 | WO2002064552A1 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES |
| 08/22/2002 | WO2002064547A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064214A2 Anti cancer combination of substituted pyrroles and paclitaxel |
| 08/22/2002 | WO2002064171A1 Adenoviral transduction of fragile histidine triad (fhit) into cancer cells |
| 08/22/2002 | WO2002064168A1 Targetted anti-tumor drug delivery systems |
| 08/22/2002 | WO2002064165A1 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same |
| 08/22/2002 | WO2002064160A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/22/2002 | WO2002064159A1 Remedies for tumor in hematopoietic organs |
| 08/22/2002 | WO2002064158A2 Use of a conjugate of il-6 and the receptor thereof for inducing cellular expression of scf and flt-3l |
| 08/22/2002 | WO2002064156A1 Selective killing of rapidly dividing cells |
| 08/22/2002 | WO2002064151A1 Acrochordon alleviation |
| 08/22/2002 | WO2002064142A1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 08/22/2002 | WO2002064138A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 08/22/2002 | WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/22/2002 | WO2002064134A2 Use of calcium indomethacin for the treatment of cyclo-oxygenase 2-mediated pathologies |
| 08/22/2002 | WO2002064132A2 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| 08/22/2002 | WO2002064127A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/22/2002 | WO2002064126A2 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | WO2002064121A1 Novel modified released formulation |
| 08/22/2002 | WO2002064118A1 Novel modified release formulation |
| 08/22/2002 | WO2002064094A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers |
| 08/22/2002 | WO2002064080A2 Matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064014A2 Endomural therapy |
| 08/22/2002 | WO2002048112A3 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 08/22/2002 | WO2002047534A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2002045652A3 Tyrosine kinase inhibitors |